Bristol Myers Squibb and Disability Solutions have together devised ‘Dubbed Disability Diversity in Clinical Trials’.
Creso Pharma signs a non-binding term sheet that will enable it to acquire Health House, an international pharmaceutical distributor in Australasia, Europe, and the UK, and it doesn’t require any legal obligations.
NHS England will leverage at-risk patients with medical tools and devices at home to enable remote monitoring for their condition.
Bristol Myers Squibb and Disability Solutions have together devised ‘Dubbed Disability Diversity in Clinical Trials’.
Creso Pharma signs a non-binding term sheet that will enable it to acquire Health House, an international pharmaceutical distributor in Australasia, Europe, and the UK, and it doesn’t require any legal obligations.
NHS England will leverage at-risk patients with medical tools and devices at home to enable remote monitoring for their condition.
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.